Muir P, Nicholson F, Illavia S J, McNeil T S, Ajetunmobi J F, Dunn H, Starkey W G, Reetoo K N, Cary N R, Parameshwar J, Banatvala J E
Department of Virology, United Medical and Dental Schools of Guy's and St Thomas' Hospitals, London.
Heart. 1996 Sep;76(3):243-9. doi: 10.1136/hrt.76.3.243.
To study the relative diagnostic value of enterovirus-specific molecular biological and serological assays in patients with end-stage dilated cardiomyopathy, and to investigate the possible role of other cardiotropic viruses in dilated cardiomyopathy.
Analysis of recipient myocardial tissue and serum from patients with dilated cardiomyopathy and controls undergoing cardiac transplantation for end-stage cardiac disease.
University virology department and transplantation unit.
Reverse transcriptase-polymerase chain reaction and nucleotide sequence analysis of myocardial RNA and DNA; enterovirus-specific in situ hybridization; enterovirus-specific immunoglobulin M detection.
Enterovirus RNA was detected in myocardial tissue from only a small proportion of (five of 75) hearts. However, although enterovirus-specific immunoglobulin M responses were detected in 22 (28%) of 39 controls patients, a significantly higher prevalence was observed among patients with dilated cardiomyopathy (22 (56%) of 39 patients; P < 0.005). All enteroviruses detected in myocardium showed greatest nucleotide sequence homology with coxsackievirus type B3. Detection of enterovirus RNA in myocardium by the polymerase chain reaction and by in situ hybridisation gave comparable results. Other potentially cardiotropic virus genomes, including human cytomegalovirus, influenzaviruses, and coronaviruses were not detected in myocardium.
This study found that enterovirus-specific immunoglobulin M responses provided the strongest evidence of enterovirus involvement in patients with end-stage dilated cardiomyopathy. However, the high background prevalence of these responses limits their diagnostic value. The finding that enteroviruses detected in myocardium were coxsackievirus type B3 accords with recent findings in patients with acute myocarditis, and indicates that this serotype is the major cardiotropic human enterovirus.
研究肠道病毒特异性分子生物学检测和血清学检测对终末期扩张型心肌病患者的相对诊断价值,并探讨其他嗜心肌病毒在扩张型心肌病中的可能作用。
分析扩张型心肌病患者及因终末期心脏病接受心脏移植的对照者的受体心肌组织和血清。
大学病毒学系和移植科。
对心肌RNA和DNA进行逆转录聚合酶链反应及核苷酸序列分析;肠道病毒特异性原位杂交;肠道病毒特异性免疫球蛋白M检测。
仅在一小部分(75例中的5例)心脏的心肌组织中检测到肠道病毒RNA。然而,虽然在39例对照患者中有22例(28%)检测到肠道病毒特异性免疫球蛋白M反应,但在扩张型心肌病患者中观察到的患病率显著更高(39例患者中有22例(56%);P<0.005)。心肌中检测到的所有肠道病毒与B3型柯萨奇病毒的核苷酸序列同源性最高。聚合酶链反应和原位杂交检测心肌中肠道病毒RNA的结果相当。心肌中未检测到其他潜在嗜心肌病毒基因组,包括人巨细胞病毒、流感病毒和冠状病毒。
本研究发现,肠道病毒特异性免疫球蛋白M反应为肠道病毒参与终末期扩张型心肌病患者提供了最有力的证据。然而,这些反应的高背景患病率限制了它们的诊断价值。心肌中检测到的肠道病毒为B3型柯萨奇病毒这一发现与急性心肌炎患者的近期研究结果一致,表明该血清型是主要的嗜心肌人肠道病毒。